Staging/typing of Lewy body related α-synuclein pathology: A study of the BrainNet Europe Consortium

Acta Neuropathologica

Volumn 117, Issue 6, 2009, Pages 635-652

  Alafuzoff, Irina ^h,p   Ince, Paul G ⁿ   Arzberger, Thomas ^m   Al Sarraj, Safa ^j   Bell, Jeanne ^e   Bodi, Istvan ^j   Bogdanovic, Nenad ^g   Bugiani, Orso ^l   Ferrer, Isidro ^c   Gelpi, Ellen ^c   Gentleman, Stephen ⁱ   Giaccone, Giorgio ^l   Ironside, James W ^e   Kavantzas, Nikolaos ^b   King, Andrew ^j   Korkolopoulou, Penelope ^b   Kovács, Gábor G ^q   Meyronet, David ^k   Monoranu, Camelia ^r   Parchi, Piero ^d   Parkkinen, Laura ^h   Patsouris, Efstratios ^b   Roggendorf, Wolfgang ^r   Rozemuller, Annemieke ^a   Stadelmann Nessler, Christine ^f   Streichenberger, Nathalie ^k   Thal, Dietmar R ^o   Kretzschmar, Hans ^m   more..

^a NETHERLANDS BRAIN BANK   (Netherlands)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UNIVERSITY OF EASTERN FINLAND   (Finland)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k UNIVERSITÉ LYON 1   (France)

^l DEPARTMENT OF NEUROSURGERY   (Italy)

^m UNIVERSITY OF MUNICH   (Germany)

ⁿ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^o UNIVERSITY OF ULM   (Germany)

^p UPPSALA UNIVERSITY   (Sweden)

^q MEDICAL UNIVERSITY OF VIENNA   (Austria)

^r UNIVERSITY OF WÜRZBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; CLINICAL PROTOCOL; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTERRATER RELIABILITY; LIMBIC SYSTEM; MALE; NEOCORTEX; PRIORITY JOURNAL; STAGING;

EID: 67349131839     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-009-0523-2     Document Type: Article

References (31)

1. Alafuzoff I, Arzberger T, Al-Sarraj S et al (2008) Staging of neurofibrillary pathology in Alzheimer's Disease. A study of the BrainNet Europe Consortium. Brain Pathol 18:484-496
2. Alafuzoff I, Parkkinen L, Al-Sarraj S et al (2008) Assessment of immunohistochemically detectable α-synuclein pathology. A study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 67:125-143
3. Beach TG, White CL, Hamilton RL et al (2008) Evaluation of α-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116:277-288
4. Beach TG, White CLIII, Hladik CL et al (2009) Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169-174
5. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211
6. Braak H, Bohl JR, Muller CM, Rub U, deVos RA, Del Tredici K (2006) Stanley Fahn lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disorders 21:2042-2051
7. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunohistochemistry. Acta Neuropathol 112:389-404
8. Croisier E, MRes DE, Deprez M et al (2006) Comparative study of commercially available anti-α-synuclein antibodies. Neuropathol Appl Neurobiol 32:351-356
9. Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413-426
10. Esiri MM, Wilcock GK (1984) The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry 47:56-60
11. Hamilton RL (2000) Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378-384
12. Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2003) Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol 105:341-350
13. Ince PG, Perry EK, Morris CM (1998) Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol 8:299-324
14. Jellinger KA (2008) A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116:1-16
15. Jellinger KA (2009) Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:215-216
16. Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: A critical analysis of α-synuclein staging. Neuropathol Appl Neurobiol 34:284-295
17. Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy Bodies and senile changes of varying degree - a new disease? Clin Neuropathol 3:185-192
18. Leverenz JB, Hamilton R, Tsuang DW et al (2009) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patients. Brain Pathol 18:220-224
19. McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy Bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47:1113-1124
20. McKeith IG, Dickson DW, Lowe J (2005) Consortium on DLB Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology 65:1863-1872
21. Müller CM, de Vos RAI, Maurage C-A, Thal DR, Tolnay M, Braak H (2005) Staging of Parkinson disease-related α-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol 64:623-628
22. Parkkinen L, Soininen H, Alafuzoff I (2003) Regional distribution of α-synuclein pathology in unimpaired aging and Alzheimer's disease. J Neuropathol Exp Neurol 62:363-367
23. Parkkinen L, Pirttilä T, Alafuzoff I (2008) Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399-407
24. Parkkinen L, Silveira-Moriyama L, Holton JL, Lees AJ, Revesz T (2009) Can olfactory bulb biopsy be justified for the diagnosis of Parkinson's disease ? Comments on "olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders". Acta Neuropathol 117:213-214
25. Perry RH, Irving D, Blessed G, Fairbain A, Perry EK (1999) Senile dementia of Lewy body type A clinical and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95:119-139
26. Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
27. Sengoku R, Saito Y, Ikemura M, Hatsuta H, Sakiyama Y, Kanemura K, Arai T, Sawabe M, Tanaka N, Mochizuki H, Inoue K, Murayama S (2008) Incidence and extent of Lewy body related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 67:1072-1083
28. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839-840
29. Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: A distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685-697
30. Ueda K, Fukushima H, Masliah E (1993) Molecular cloning of cDNA encoding an unrecognizable component of amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 90:11282-11286
31. Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns of stages of α-synucleinopathy. Relevance in a population-based cohort. Neurology 70:1042-1048